These studies showed that exposure to cytokines like TGF-β in the tumor microenvironment can regulate the plasticity of ILC1-NK cells which can affect the biological endpoint such as allowing the tumors to escape immune surveillance. This evidence concerns the gene TGFB1 and neoplasm.